However, how IGF2BP3 induces this immunosuppressive polarization remains largely unknown, and further studies will help to elucidate the effects of IGF2BP3 on GBM cells and its immune microenvironment, thereby providing a basis for the diagnosis and treatment of glioma. This evidence concerns the gene IGF2BP3 and glioma.